Page 50 - Complementary and Alternative Medicine Treatments in Psychiatry
P. 50

50  |  Complementary and Alternative Medicine Treatments in Psychiatry

          bipolar disorder, raising the possibility of the use of folate in
          treatment and prevention.” (Gilbody 2007)


          Vitamin B12
          Cobalamin, commonly known as vitamin B12, is another link in
          the methylation cycle. Psychiatric signs of deficiency include
          concentration difficulties, confusion, irritation, impaired
          memory, dementia, irritability, depression, personality changes,
          and psychosis.
           Psychiatric symptoms may exist despite the absence of typical
          blood or neurologic symptoms common with B12 deficiency.
          Psychosis may respond to supplementation, even after a
          prolonged period of cobalamin deficiency. B12-related mental
          disorders can manifest even with low-to-moderate B12 serum
          levels. If homocysteine or methylmalonic acid levels are
          elevated, despite “normal” B12 levels, a deficiency could be
          indicated. This is a particular issue with the elderly, who
          commonly experience B12 deficiency, in part due to a scarcity of
          intrinsic factor, a glycoprotein that aids in B12 absorption
          (Sabeen 2009). For these patients, injected B12 may prove more
          effective than supplements taken orally. It should be noted that
          some non-elderly also do not produce sufficient intrinsic factor
          and are at risk for psychiatric symptoms due to B12 deficiency,
          as are vegans and vegetarians.
           Recent research suggests that B12 supplementation may reduce
          the risk of Alzheimer’s disease. In Finland 271 people, age 65 to
          79, were selected who did not have dementia at the start of the
          study. Over a seven-year span, 17 people developed AD.
          Researchers found that, as homocysteine levels rose (a factor of
          B12 deficiency), the likelihood of AD increased. The same was
          true as B12 levels dropped (Hooshmand 2010).
           B12 has been found as a marker of how well people will respond
          to treatment for depression. In another Finnish study,
          researchers monitored 115 patients suffering from depression
          over a six-month period and grouped them according to how
   45   46   47   48   49   50   51   52   53   54   55